Veracyte | VCYT - 销售收入



金融业
股票价格
USD
资产
USD 1.49B
现金及等价物
USD 299.52M
销售成本
USD 42.19M
流动资产
USD 574.78M
流动负债
USD 62.74M
债务
USD 39.33M
EBIT
USD 23.96M
EBITDA
USD 43.96M
员工
824
EPS每股收益
USD 0.54
股本和储备
USD 1.39B
销售毛利
USD 108.55M
债务利息支出
USD 2K
利息收入
USD 3.48M
贷款资金
USD 0
市值
USD 3.43B
净收入
USD 25.49M
营业费用
USD 126.36M
营业利润
USD 23.96M
普通股股本
USD 79.79M
PE价格收益
42.77
税前利润
USD 26.52M
销售收入
USD 150.32M
销售和管理费用
USD 55.71M
股票
USD 22.66M
贸易债权人
USD 8.02M
应收帐款人
USD 54.18M


销售 更改 日
Agenus USD 33.7M 500K 2026-03
Agilent USD 1.88B 43M 2026-06
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 75.23M 1.49M 2026-06
Bruker USD 838.5M 15.1M 2026-06
Heron Therapeutics USD 40.59M 2.38M 2025-12
Illumina USD 1.16B 70M 2026-06
Intrexon USD 717K 511K 2024-06
Karyopharm Therapeutics USD 35.07M 987K 2026-03
Laboratory Of America USD 3.73B 190M 2026-06
Ligand Pharmaceuticals USD 83.7M 31.98M 2026-06
Myriad Genetics USD 190.7M 9.7M 2026-06
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Siemens EUR 20.79B 1.03B 2026-06
Sonic Healthcare AUD 5.42B 30M 2026-06
Thermo Fisher Scientific USD 11.99B 980M 2026-06
Veracyte USD 150.32M 11.25M 2026-06
Waters USD 1.64B 370M 2026-06